Observational studyActa neurochirurgica2026
Creatine kinase level elevation as a marker for motor deficits and symptom duration in lumbar disc herniation patients.
Observational study in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLumbar disc herniation (LDH) accompanied by muscle paresis causes functional limitations. There is no biomarker for motor deficit in LDH. The association between serum creatine kinase (CK) and muscle paresis has not been well defined.
objectivesThis study aims to compare serum CK levels in LDH patients with and without motor deficits, and to correlate CK levels with clinical characteristics (age, BMI, symptom duration, affected myotome, motor deficit grade) to assess the potential of CK as a biomarker.
methodsThis study represents a single-institution retrospective analysis of a prospective observational cohort. Admission, baseline, and delta (Δ) CK levels were compared between patients with and without motor deficits and across symptom duration using ANOVA. To examine the relationship between CK and clinical variables (age, BMI, symptom duration, primary myotome, secondary myotome, primary Medical Research Council (MRC), and secondary MRC), a Generalized Additive Model (GAM) was used. Symptom duration was categorized. Motor deficit grade was measured using MRC scale for muscle strength.
resultsA total of 87 patients (no motor deficits N = 32 [37%], motor deficits (N = 55 [63%]) were included in the study. We observed a trend to elevated CK (p = 0.051) in those with motor deficits. CK elevation was present in 0-3 days (ΔCK = 48 U/L) and peaked in those with 4-7 days (ΔCK = 317 U/L) of symptoms before reaching baseline level. In the GAM model, the MRC grade (p = 0.022) of the predominantly affected myotome correlated significantly with the CK level at admission. Higher CK levels were found in patients with more than one myotome affected.
conclusionThese findings suggest that CK level elevation correlates with the primary MRC grade and by the number of affected myotomes. Further prospective studies are warranted to validate CK's diagnostic value in this setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.